570
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Epitope-specific immune recognition of the nontypeable Haemophilus influenzae outer membrane protein 26

, , , , , & show all
Pages 625-635 | Received 10 Oct 2012, Accepted 25 Oct 2012, Published online: 04 Jan 2013

References

  • Munson RS Jr.. Haemophilus influenzae: surface antigens and aspects of virulence. Can J Vet Res 1990; 54:Suppl S63 - 7; PMID: 2193707
  • Murphy TF, Bartos LC. Human bactericidal antibody response to outer membrane protein P2 of nontypeable Haemophilus influenzae. Infect Immun 1988; 56:2673 - 9; PMID: 2843467
  • Neary JM, Yi K, Karalus RJ, Murphy TF. Antibodies to loop 6 of the P2 porin protein of nontypeable Haemophilus influenzae are bactericidal against multiple strains. Infect Immun 2001; 69:773 - 8; http://dx.doi.org/10.1128/IAI.69.2.773-778.2001; PMID: 11159967
  • Yi K, Murphy TF. Mapping of a strain-specific bactericidal epitope to the surface-exposed loop 5 on the P2 porin protein of non-typeable Haemophilus influenzae. Microb Pathog 1994; 17:277 - 82; http://dx.doi.org/10.1006/mpat.1994.1073; PMID: 7536289
  • Bakaletz LO, Leake ER, Billy JM, Kaumaya PTP. Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeable Haemophilus influenzae in the chinchilla. Vaccine 1997; 15:955 - 61; http://dx.doi.org/10.1016/S0264-410X(96)00298-8; PMID: 9261941
  • Bakaletz LO, Kennedy B-J, Novotny LA, Duquesne G, Cohen J, Lobet Y. Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection. Infect Immun 1999; 67:2746 - 62; PMID: 10338477
  • Bakaletz LO. Peptide and recombinant antigens for protection against bacterial middle ear infection. Vaccine 2001; 19:2323 - 8; http://dx.doi.org/10.1016/S0264-410X(00)00522-3; PMID: 11257356
  • Webb DC, Cripps AWA. A P5 peptide that is homologous to peptide 10 of OprF from Pseudomonas aeruginosa enhances clearance of nontypeable Haemophilus influenzae from acutely infected rat lung in the absence of detectable peptide-specific antibody. Infect Immun 2000; 68:377 - 81; http://dx.doi.org/10.1128/IAI.68.1.377-381.2000; PMID: 10603411
  • Kyd JM, Dunkley ML, Cripps AW. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model. Infect Immun 1995; 63:2931 - 40; PMID: 7622215
  • Hotomi M, Yamanaka N, Saito T, Shimada J, Suzumoto M, Suetake M, et al. Antibody responses to the outer membrane protein P6 of non-typeable Haemophilus influenzae and pneumococcal capsular polysaccharides in otitis-prone children. Acta Otolaryngol 1999; 119:703 - 7; http://dx.doi.org/10.1080/00016489950180667; PMID: 10587005
  • Sabirov A, Kodama S, Hirano T, Suzuki M, Mogi G. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media. Infect Immun 2001; 69:2964 - 71; http://dx.doi.org/10.1128/IAI.69.5.2964-2971.2001; PMID: 11292713
  • Barenkamp SJ, Bodor FF. Development of serum bactericidal activity following nontypable Haemophilus influenzae acute otitis media. Pediatr Infect Dis J 1990; 9:333 - 9; http://dx.doi.org/10.1097/00006454-199005000-00006; PMID: 2352818
  • Gu X-X, Tsai C-M, Ueyama T, Barenkamp SJ, Robbins JB, Lim DJ. Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins. Infect Immun 1996; 64:4047 - 53; PMID: 8926067
  • DeMaria TF, Apicella MA, Nichols WA, Leake ER. Evaluation of the virulence of nontypeable Haemophilus influenzae lipooligosaccharide htrB and rfaD mutants in the chinchilla model of otitis media. Infect Immun 1997; 65:4431 - 5; PMID: 9353016
  • Gu X-X, Rudy SF, Chu C, McCullagh L, Kim HN, Chen J, et al. Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae. Vaccine 2003; 21:2107 - 14; http://dx.doi.org/10.1016/S0264-410X(02)00768-5; PMID: 12706701
  • Kyd JM, Cripps AW. Potential of a novel protein, OMP26, from nontypeable Haemophilus influenzae to enhance pulmonary clearance in a rat model. Infect Immun 1998; 66:2272 - 8; PMID: 9573117
  • El-Adhami W, Kyd JM, Bastin DA, Cripps AW. Characterization of the gene encoding a 26-kilodalton protein (OMP26) from nontypeable Haemophilus influenzae and immune responses to the recombinant protein. Infect Immun 1999; 67:1935 - 42; PMID: 10085039
  • Kyd JM, Cripps AW, Novotny LA, Bakaletz LO. Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx. Infect Immun 2003; 71:4691 - 9; http://dx.doi.org/10.1128/IAI.71.8.4691-4699.2003; PMID: 12874350
  • Murphy TF, Apicella MA. Antigenic heterogeneity of outer membrane proteins of nontypable Haemophilus influenzae is a basis for a serotyping system. Infect Immun 1985; 50:15 - 21; PMID: 3876283
  • Weinberg GA, Lehmann D, Tupasi TE, Granoff DM. Diversity of outer membrane protein profiles of nontypable Haemophilus influenzae from children from Papua New Guinea and the Philippines. Rev Infect Dis 1990; 12:Suppl 8 S1017 - 20; http://dx.doi.org/10.1093/clinids/12.Supplement_8.S1017; PMID: 2270398
  • van Alphen L, Caugant DA, Duim B, O’Rourke M, Bowler LD. Differences in genetic diversity of nonecapsulated Haemophilus influenzae from various diseases. Microbiology 1997; 143:1423 - 31; http://dx.doi.org/10.1099/00221287-143-4-1423; PMID: 9141705
  • Porras O, Caugant DA, Lagergård T, Svanborg-Edén C. Application of multilocus enzyme gel electrophoresis to Haemophilus influenzae. Infect Immun 1986; 53:71 - 8; PMID: 3522433
  • Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, et al. Peptide vaccines incorporating a ‘promiscuous’ T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity. J Mol Recognit 1993; 6:81 - 94; http://dx.doi.org/10.1002/jmr.300060206; PMID: 7508238
  • Sunakawa K, Takeuchi Y, Iwata S. [Nontypeable Haemophilus influenzae (NTHi) epidemiology]. Kansenshogaku Zasshi 2011; 85:227 - 37; PMID: 21706841
  • Williams KM, Bigley EC 3rd, Raybourne RB. Identification of murine B-cell and T-cell epitopes of Escherichia coli outer membrane protein F with synthetic polypeptides. Infect Immun 2000; 68:2535 - 45; http://dx.doi.org/10.1128/IAI.68.5.2535-2545.2000; PMID: 10768941
  • Adorini L, Nagy ZA. Peptide competition for antigen presentation. Immunol Today 1990; 11:21 - 4; http://dx.doi.org/10.1016/0167-5699(90)90006-U; PMID: 2405874
  • Todryk SM, Kelly CG, Lehner T. Effect of route of immunisation and adjuvant on T and B cell epitope recognition within a streptococcal antigen. Vaccine 1998; 16:174 - 80; http://dx.doi.org/10.1016/S0264-410X(97)00183-7; PMID: 9607027
  • Thatte J, Rath S, Bal V. Analysis of immunization route-related variation in the immune response to heat-killed Salmonella typhimurium in mice. Infect Immun 1995; 63:99 - 103; PMID: 7806391
  • Gutierro I, Hernández RM, Igartua M, Gascón AR, Pedraz JL. Influence of dose and immunization route on the serum Ig G antibody response to BSA loaded PLGA microspheres. Vaccine 2002; 20:2181 - 90; http://dx.doi.org/10.1016/S0264-410X(02)00146-9; PMID: 12009271
  • Partidos CD, Vohra P, Stanley CM, Howard CR, Steward MW. Induction of systemic immune responses to orally administered synthetic peptides. Vaccine Res 1995; 4:113 - 20
  • Scheerlinck J-PY, DeLeys R, Saman E, Brys L, Geldhof A, De Baetselier P. Redistribution of a murine humoral immune response following removal of an immunodominant B cell epitope from a recombinant fusion protein. Mol Immunol 1993; 30:733 - 9; http://dx.doi.org/10.1016/0161-5890(93)90144-Z; PMID: 7684820
  • Partidos CD, Salani FB, Ripley J, Steward MW. Deconstructing the antigenic profile of a protective epitope from measles virus fusion protein using overlapping peptides. Vaccine 1999; 18:321 - 4; http://dx.doi.org/10.1016/S0264-410X(99)00211-X; PMID: 10506658
  • Van Regenmortel MHV. Antigenicity and immunogenicity of synthetic peptides. Biologicals 2001; 29:209 - 13; http://dx.doi.org/10.1006/biol.2001.0308; PMID: 11851317
  • Lajmi AR, Wallace TR, Shin JA. Short, hydrophobic, alanine-based proteins based on the basic region/leucine zipper protein motif: overcoming inclusion body formation and protein aggregation during overexpression, purification, and renaturation. Protein Expr Purif 2000; 18:394 - 403; http://dx.doi.org/10.1006/prep.2000.1209; PMID: 10733895
  • Murphy TF, Kyd JM, John A, Kirkham C, Cripps AW. Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model. J Infect Dis 1998; 178:1667 - 75; http://dx.doi.org/10.1086/314501; PMID: 9815219
  • Kyd J, John A, Cripps A, Murphy TF. Investigation of mucosal immunisation in pulmonary clearance of Moraxella (Branhamella) catarrhalis. Vaccine 1999; 18:398 - 406; http://dx.doi.org/10.1016/S0264-410X(99)00262-5; PMID: 10519928
  • Novotny LA, Jurcisek JA, Pichichero ME, Bakaletz LO. Epitope mapping of the outer membrane protein P5-homologous fimbrin adhesin of nontypeable Haemophilus influenzae. Infect Immun 2000; 68:2119 - 28; http://dx.doi.org/10.1128/IAI.68.4.2119-2128.2000; PMID: 10722609
  • Malmqvist M. Epitope Mapping by Label-Free Biomolecular Interaction Analysis. Methods 1996; 9:525 - 32; http://dx.doi.org/10.1006/meth.1996.0060; PMID: 8812708
  • Johne B. Epitope mapping by surface plasmon resonance in the BIAcore. Mol Biotechnol 1998; 9:65 - 71; http://dx.doi.org/10.1007/BF02752698; PMID: 9592769
  • Groeneveld K, van Alphen L, Voorter C, Eijk PP, Jansen HM, Zanen HC. Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease. Infect Immun 1989; 57:3038 - 44; PMID: 2789192

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.